日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Primary Analysis of a Phase II Study of Atezolizumab plus Bevacizumab for TACE-Unsuitable Patients with Tumor Burden beyond Up-To-Seven Criteria in Intermediate-Stage Hepatocellular Carcinoma: REPLACEMENT Study

一项针对不适合接受经导管动脉化疗栓塞术(TACE)且肿瘤负荷超过“Up-To-7”标准的中晚期肝细胞癌患者的阿特珠单抗联合贝伐珠单抗治疗的II期研究的主要分析:REPLACEMENT研究

Kudo, Masatoshi; Ueshima, Kazuomi; Tsuchiya, Kaoru; Yamashita, Tatsuya; Shimose, Shigeo; Numata, Kazushi; Kodama, Yuzo; Itoh, Shinji; Tanaka, Yasuhito; Kuroda, Hidekatsu; Aikata, Hiroshi; Hiraoka, Atsushi; Moriguchi, Michihisa; Tateishi, Ryosuke; Ogasawara, Sadahisa; Yamamoto, Kouji; Ikeda, Masafumi

MVI-targeted carbon-ion radiotherapy combined with immunotherapy for advanced hepatocellular carcinoma: Phase Ib DEPARTURE trial

针对晚期肝细胞癌的MVI靶向碳离子放射疗法联合免疫疗法:Ib期DEPARTURE试验

Ogasawara, Sadahisa; Koroki, Keisuke; Makishima, Hirokazu; Wakatsuki, Masaru; Takahashi, Asahi; Fujiya, Makoto; Yumita, Sae; Nakagawa, Miyuki; Kanzaki, Hiroaki; Kobayashi, Kazufumi; Inoue, Masanori; Nakamura, Masato; Kanogawa, Naoya; Kondo, Takayuki; Nakamoto, Shingo; Kurokawa, Tomoya; Ozawa, Yoshihito; Inaba, Yosuke; Paritala, Soumith; Chen, Jingxuan; Lee, Jeon; Hoshida, Yujin; Hanaoka, Hideki; Yamada, Shigeru; Ishikawa, Hitoshi

Cholestasis-reducing effects of bezafibrate on survivors of biliary atresia with native livers: A prospective phase II trial

贝扎贝特对胆道闭锁幸存者(肝脏功能正常)的胆汁淤积减少作用:一项前瞻性 II 期试验

Kawaguchi, Yunosuke; Terui, Keita; Fumita, Takashi; Shibata, Ryohei; Yoshizawa, Hiroko; Ogasawara, Sadahisa; Kondo, Takayuki; Ozawa, Yoshihito; Inaba, Yosuke; Hishiki, Tomoro

Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post-Progression Outcomes: A Multicenter Real-World Study in Advanced Hepatocellular Carcinoma

阿特珠单抗联合贝伐珠单抗可实现持久的疾病控制,但疾病进展后的疗效有限:一项针对晚期肝细胞癌的多中心真实世界研究

Inoue, Masanori; Ogasawara, Sadahisa; Asahara, Kazuhisa; Sato, Rui; Watanabe, Shunji; Anzai, Haruka; Tsubura, Kazuo; Watabe, Taro; Fujiya, Makoto; Akatsuka, Teppei; Izai, Ryo; Katayama, Keiichi; Sawada, Midori; Tsuchiya, Takahiro; Miwa, Chihiro; Yoshino, Ryohei; Yonemoto, Takuya; Fujimoto, Kentaro; Unozawa, Hidemi; Yumita, Sae; Kanzaki, Hiroaki; Koroki, Keisuke; Kobayashi, Kazufumi; Nakamura, Masato; Kanogawa, Naoya; Nakamoto, Shingo; Yokoyama, Masayuki; Kato, Jun; Moriguchi, Michihisa; Aramaki, Takeshi; Morimoto, Naoki

Exploratory case series of conversion to carbon ion radiotherapy after systemic therapy in advanced hepatocellular carcinoma

晚期肝细胞癌全身治疗后转换为碳离子放射治疗的探索性病例系列研究

Anzai, Haruka; Miwa, Chihiro; Ogasawara, Sadahisa; Fujiya, Makoto; Kurosaki, Hiroki; Tsuchiya, Takahiro; Yoshino, Ryohei; Katayama, Keiichi; Sawada, Midori; Akatsuka, Teppei; Izai, Ryo; Yonemoto, Takuya; Yumita, Sae; Koroki, Keisuke; Inoue, Masanori; Nakamura, Masato; Kanogawa, Naoya; Nakamoto, Shingo; Makishima, Hirokazu; Shinoto, Makoto; Wakatsuki, Masaru; Yamada, Shigeru; Ishikawa, Hitoshi; Kato, Jun

Comprehensive Analysis of Radiologic Cancer-Free Status through Various Treatment Approaches in Advanced-Stage Hepatocellular Carcinoma

晚期肝细胞癌不同治疗方法下放射学无癌状态的综合分析

Koroki, Keisuke; Ogasawara, Sadahisa; Izai, Ryo; Yonemoto, Takuya; Akatsuka, Teppei; Miwa, Chihiro; Yumita, Sae; Inoue, Masanori; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Kondo, Takayuki; Nakamoto, Shingo; Nakada, Shinichiro; Sakai, Nozomu; Yokoyama, Masayuki; Ohtsuka, Masayuki; Kato, Naoya

Assessment of Macrovascular Invasion in Advanced Hepatocellular Carcinoma: Clinical Implications and Treatment Outcomes with Systemic Therapy

晚期肝细胞癌大血管侵犯的评估:临床意义及全身治疗的疗效

Inoue, Masanori; Ogasawara, Sadahisa; Kobayashi, Kazufumi; Okubo, Tomomi; Itokawa, Norio; Obu, Masamichi; Fujimoto, Kentaro; Unozawa, Hidemi; Yumita, Sae; Fujiwara, Kisako; Nakagawa, Miyuki; Kanzaki, Hiroaki; Koroki, Keisuke; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Kondo, Takayuki; Nakamoto, Shingo; Nagashima, Kengo; Itobayashi, Ei; Atsukawa, Masanori; Koma, Yoshihiro; Azemoto, Ryosaku; Kato, Naoya

Randomized phase II study comparing two doses of regorafenib in second-line treatment for advanced hepatocellular carcinoma

一项随机II期研究比较了两种剂量的瑞戈非尼在晚期肝细胞癌二线治疗中的疗效

Koroki, Keisuke; Ogasawara, Sadahisa; Yumita, Sae; Nakagawa, Miyuki; Kanzaki, Hiroaki; Kobayashi, Kazufumi; Inoue, Masanori; Nakamura, Masato; Kanogawa, Naoya; Kondo, Takayuki; Suzuki, Eiichiro; Ooka, Yoshihiko; Nakamoto, Shingo; Shiko, Yuki; Ozawa, Yoshihito; Inaba, Yosuke

The efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in relation to tumor-infiltrating lymphocytes

阿特珠单抗联合贝伐珠单抗治疗晚期肝细胞癌的疗效与肿瘤浸润淋巴细胞的关系

Kanzaki, Hiroaki; Ishino, Takamasa; Ogasawara, Sadahisa; Tsuchiya, Takahiro; Fujiya, Makoto; Sawada, Midori; Izai, Ryo; Akatsuka, Teppei; Miwa, Chihiro; Yonemoto, Takuya; Yumita, Sae; Nakagawa, Miyuki; Kojima, Ryuta; Koroki, Keisuke; Inoue, Masanori; Kobayashi, Kazufumi; Kanogawa, Naoya; Nakamura, Masato; Kondo, Takayuki; Nakamoto, Shingo; Takayashiki, Tsukasa; Takano, Yuka; Takata, Kaho; Lin, Jason; Kawazu, Masahito; Ikeda, Jun-Ichiro; Ohtsuka, Masayuki; Hoshida, Yujin; Komuta, Mina; Togashi, Yosuke

Atezolizumab Plus Bevacizumab for TACE-Unsuitable Intermediate-Stage HCC Beyond Up-To-7 Criteria: Final Analysis of REPLACEMENT

阿特珠单抗联合贝伐珠单抗治疗不适合经TACE治疗且超出Up-To-7标准的中晚期肝细胞癌:REPLACEMENT研究的最终分析

Ueshima, Kazuomi; Tsuchiya, Kaoru; Yamashita, Tatsuya; Shimose, Shigeo; Numata, Kazushi; Kodama, Yuzo; Itoh, Shinji; Tanaka, Yasuhito; Kuroda, Hidekatsu; Ohkawa, Kazuyoshi; Kuzuya, Teiji; Ikeda, Masafumi; Kooka, Youhei; Aikata, Hiroshi; Hiraoka, Atsushi; Moriguchi, Michihisa; Tateishi, Ryosuke; Ogasawara, Sadahisa; Yamamoto, Kouji; Kudo, Masatoshi